IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Passage BIO Inc (PASG)

CUSIP: 702712209 | NYSE | Healthcare · Biotechnology | Micro Cap | 52 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AVestal Point Capital, LP00.0%No shares heldJun 30, 2026No 13F filer matched
13G/AVestal Point Capital, LP0
0.0% of class · Jun 30, 2026

Institutional Holders — Q3 2026

Deltec Asset Management LLC15,000
0.0% of portfolio›$67.5K
SBI Securities Co., Ltd.181
0.0% of portfolio›$815
StyleTurnoverLocationFiled
Deltec Asset Management LLC
15,000$67.5K0.0%CoreMediumNew York, NY2026-10-26
SBI Securities Co., Ltd.
181$8150.0%Agg GrowthLowTokyo, Mexico2026-10-22
No shares held
No 13F filer matched